Providing market intelligence for more than 35 years

In The News

Amazon Fire TV is selling better than Apple TV

Will the rumored new model help Apple TV get back up the rankings?

If recently released data from Parks Associates is correct, Apple TV slipped down from third to fourth place in the rankings of the most popular streaming media device based on U.S. sales for 2014.

The reason for Apple TV’s fall? Amazon’s Fire TV and Fire Stick, introduced last year. According to the data, Roku is currently in the top spot with 34% of the market, followed by Google’s Chromecast with 23%. As 9to5Mac points out, however, the rumors of an upcoming new version of Apple TV likely had an impact on sales with some consumers opting to wait for the new model. According to rumors, Apple will unveil a new model at its press event on September 9, alongside a new iPhone, a new iPad, and more.

From the article "Amazon Fire TV is selling better than Apple TV" by Kia Kokalitcheva.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...